Share this PR

Press Contact

Mr. Rohan

Markets And Markets

Contact Email

Social Media

Medical Radiation Detection, Monitoring, and Safety Market worth 1,215.4 Million USD by 2021

PressReleasePing - March 29, 2017 -Browse 163 market data tables and 35 figures spread through 189 pages and in-depth TOC on "Medical Radiation Detection, Monitoring & Safety Market by Detection Type (Gas-Filled Detectors, Geiger Muller, Survey Meter, Solid-State), Products (Personal Dosimeters, OSL, Badges), Safety (Apron, Shields, Face Mask, Gloves), End User - Forecast to 2021" http://www.marketsandmarkets.com/Market-Reports/medical-radiation-protection-market-1200.html Early buyers will receive 10% customization on reports. The medical radiation detection, monitoring, and safety market is expected to reach USD 1,215.4 Million by 2021 from USD 887.0 Million in 2016, at a CAGR of 6.5% from 2016 to 2021. The major factors driving the growth of this market are the increasing usage of nuclear medicine and radiation therapy for diagnosis and treatment, growing incidence of cancer, increasing safety awareness among people working in radiation-prone environments, growing healthcare industry worldwide, and rising insurance coverage. The report segments this market based on detectors, detection and monitoring products, safety products, end users, and regions. On the basis of detector, the medical radiation detection and monitoring market is segmented into gas-filled detectors, scintillators, and solid-state detectors. In 2016, the gas-filled detectors segment dominated the global medical radiation detection and monitoring market. The growth of this segment is mainly due to the favorable performance-to-cost ratio of gas-filled detectors coupled with their wide application in the medical imaging field. On the basis of product, the medical radiation detection and monitoring market is segmented into personal dosimeters, area process monitors, environment radiation monitors, surface contamination monitors, radioactive material monitors, and other products. In 2016, the personal dosimeters segment accounted for the largest share of the medical radiation detection and monitoring market. The growth of this segment can be attributed to the high demand for personal dosimeters in the medical field. On the basis of product, the medical radiation safety market is segmented into full-body protection products, face protection products, hand safety products, and other safety products. The full-body protection products segment is expected to grow at the highest CAGR during the forecast period. The increase in the number of radiological procedures and awareness among physicians, radiologists, and patients are driving the growth of the full-body protection products market. On the basis of end user, the medical radiation detection, monitoring, and safety market is classified into hospitals and non-hospitals. In 2016, the hospitals segment accounted for the largest share and is projected to grow at the highest rate during the forecast period. The increasing number of hospitals across the globe is a major factor driving the market growth in this end-user segment. On the basis of region, the medical radiation detection, monitoring, and safety market is segmented into North America, Europe, Asia, and the Rest of the World (RoW). In 2016, North America dominated the medical radiation detection, monitoring, and safety market. On the other hand, the Asian region is expected to grow at the fastest growth rate due to the growing number of hospitals, rising incidence of cancer, increasing installations of radiological imaging systems, and rising adoption of radiation therapy for the treatment of diseases. Key players in the medical radiation detection, monitoring, and safety market are Landauer, Inc. (U.S.), Mirion Technologies, Inc. (U.S.), IBA Worldwide (Belgium), Thermo Fisher Scientific (U.S.), Sun Nuclear Corporation (U.S.), Ludlum Measurements, Inc. (U.S.), Radiation Detection Company, Inc. (U.S.), Biodex Medical Systems, Inc. (U.S.), Arrow-Tech, Inc. (U.S.), Fluke Biomedical (U.S.), AmRay Medical (Ireland), Infab Corporation (U.S.), and PTW Freiburg GmbH (Germany).

Creative Commons License

This press release is licensed under a Creative Commons Attribution 3.0 Unported License.